Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03102414

Ligand	Ligand name	Chain	PDB	Tanimoto
BB1	2-[(FORMYL-HYDROXY-AMINO)-METHYL]-HEXANOIC ACID (1-DIMETHYLCARBAMOYL-2,2-DIMETHYL-PROPYL)-AMIDE	A,B,C	1G27	0.75
BPR	(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE	A,B,C,D	2AJD	0.74
PPL	PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE	A,B	1IDB	0.77
PPL	PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE	A,B	1IDA	0.77
1AD	(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE	A	2GBG	0.74
CIB	2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE	H,I,J,K,L,M,N	1J2Q	0.79
HU5	(1R,2S,5S)-N-[(1S)-3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL]-3-[(2S)-2-{[(TERT-BUTYLAMINO)CARBONYL]AMINO}-3,3-DIMETHYLBUTANOYL]-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE	A,C	2OC8	0.74
ALJ	CYCLO-(L-ARGININE-L-PROLINE) INHIBITOR	A,B	1W1V	0.75
BE8		A,C	3EYD	0.74
AIA	(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE	A	2GBF	0.72
HUD	TERT-BUTYL [(1S)-1-{[(1R,2S,5S)-2-({[(1S)-3-AMINO-1-(CYCLOPROPYLMETHYL)-2,3-DIOXOPROPYL]AMINO}CARBONYL)-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEX-3-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE	A,C	2OBO	0.74
277	N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE	A,B	2OPH	0.77
A3M	2-AMINO-3-METHYL-1-PYRROLIDIN-1-YL-BUTAN-1-ONE	A,B	1N1M	0.74
HU1	TERT-BUTYL {(1S)-2-[(1R,2S,5S)-2-({[(1S)-3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL]AMINO}CARBONYL)-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEX-3-YL]-1-CYCLOHEXYL-2-OXOETHYL}CARBAMATE	A,C	2OC0	0.71
AIO	[(2R)-1-(L-ALANYL-L-ISOLEUCYL)PYRROLIDIN-2-YL]BORONIC ACID	A	2EEP	0.82
AIO	[(2R)-1-(L-ALANYL-L-ISOLEUCYL)PYRROLIDIN-2-YL]BORONIC ACID	A	2Z3Z	0.82
INN	3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]-4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL-L-ALANINE	A,B	3EDZ	0.75
INN	3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]-4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL-L-ALANINE	A,B	3EWJ	0.75
INN	3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]-4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL-L-ALANINE	A,B	2DDF	0.75
INN	3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]-4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL-L-ALANINE	A,B,C,D	2I47	0.75
INN	3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]-4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL-L-ALANINE	A,C,E,I	1BKC	0.75
INN	3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]-4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL-L-ALANINE	A,B	2FV9	0.75
INN	3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]-4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL-L-ALANINE	A,B	3E8R	0.75
GIO	CYCLO-(GLYCINE-L-PROLINE) INHIBITOR	A,B	1W1P	0.76
OHM	3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE	B,H	2NTF	0.72
KCQ	(3S)-3-[(2S)-2-AMINO-3-OXOBUTYL]PYRROLIDIN-2-ONE	A,I	2Z3E	0.74